Ohio State University Wexner Medical Center
Columbus, Ohio, 43210, United States
Location status: Recruiting
NCT Number: NCT06118567
The goal of this experimental medicine clinical trial is to test the hypothesis that nitrous oxide inhalation will result in a change in neurocircuit function in healthy controls and in individuals with impulsive aggressive tendencies. The main question aims to answer are: Does Nitrous Oxide normalize brain circuit function in impulsively aggressive individuals 24 hours after inhalation. Participants will undergo a 60 minute inhalation session with 50% Nitrous Oxide (or room air at another session) and then undergo an fMRI scan 24 hours later. Researchers will compare healthy controls and impulsively aggressive individuals to see if Nitrous Oxide can normalize the function of cortico-limbic circuits in the latter group.
Interested in participating?
Request Info21 year–55 year
All sexes
Interventional
Phase 2
Columbus, Ohio, 43210, United States
Location status: Recruiting
This study is designed to see if inhalation of 50% nitrous oxide (N2O) also known as laughing gas, can normalize cortico-limbic circuit functioning in impulsively aggressive human subjects. If the study results are positive, it would allow further studies of this potential treatment modality for those with recurrent, problematic, impulsive aggressive behavior (Intermittent Explosive Disorder: IED). IED is a disorder in which there are frequent and sudden outbursts of anger (yelling, throwing and breaking things, hitting people) that lead to problems with other people socially or at work. It affects about 4% of the US population lifetime, and does not have any approved treatments. The study will test if N2O can normalize brain activity 24 hours after infusion, in participants with a diagnosis of IED compared with healthy, non-aggressive, controls. This is a double-blinded-randomized study with comparison between groups (controls and IED patients) and comparison for each participant between N2O and placebo (air) inhalation. Participants will receive one type of inhalation 24 hours before undergoing an fMRI. Participants will be randomized to the order in which they receive N2O or air. Participants and study personnel involved in collection of outcome measures will be blinded to the type of inhalation. The study includes up to 7 visits. Visits 1/2 include interviews and questionnaires. At visits 3 and 5, participants receive the N2O or air inhalation. At visits 4 and 6, participants undergo fMRI while completing computer tasks. Visit 7 is to assure data collection is complete.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
All participants:
Aggressive (IED) Study Participants (n = 25 Completed; 75 Enrolled).
Healthy, Non-Aggressive, Controls (n = 25 Completed, 75 Enrolled).
Exclusion criteria
Nitrous oxide gas.
Room Air
Time frame: 24 hours after Nitrous Oxide and Room Air
Orbito-Frontal and Amygdala responses to Anger Faces in fMRI
Time frame: 24 hours after Nitrous Oxide and Room Air
Resting State
Contact information is provided by the study sponsor or research team.
Jayla Copland, B.A.
CONTACT
Julian Roberts, R.N.
CONTACT
Ohio State University
Other
Nitrous Oxide and Cortico-Limbic Function in Aggression
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06665074
Aberrant Motor Behavior in Dementia, Aggression
Columbus, Ohio, United States
View Trial DetailsNCT05895513
Aberrant Motor Behavior in Dementia, Aggression
Columbus, Ohio, United States
View Trial DetailsNCT06118580
Alcohol Use Disorder, Alcohol-Related Disorders
Columbus, Ohio, United States
View Trial DetailsNCT00667212
Anger, Disruptive, Impulse Control, and Conduct Disorders
Chicago, Illinois, United States
View Trial Details